As previously mentioned, CKMT2-AS1 demonstrates substantial downregulation in CRC9 and breast cancer tissues,10 where it plays a role in biological processes such as autophagy by modulating the activity of downstream target genes. This evidence concerns the gene CKMT2 and breast carcinoma.